Clinical trials
Completed Phase 2 Kidney Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
140 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 10 |
| 2001 | 10 |
| 2002 | 8 |
| 2003 | 10 |
| 2004 | 14 |
| 2005 | 7 |
| 2006 | 14 |
| 2007 | 13 |
| 2008 | 4 |
| 2009 | 7 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 2 |
| 2020 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 140 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 16 |
| Memorial Sloan Kettering Cancer Center | 12 |
| M.D. Anderson Cancer Center | 8 |
| Case Comprehensive Cancer Center | 6 |
| Eastern Cooperative Oncology Group | 5 |
| Pfizer | 4 |
| Alliance for Clinical Trials in Oncology | 3 |
| Amgen | 3 |
| Barbara Ann Karmanos Cancer Institute | 3 |
| H. Lee Moffitt Cancer Center and Research Institute | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kidney Neoplasms | 140 |
| Carcinoma, Renal Cell | 103 |
| Neoplasm Metastasis | 12 |
| Sarcoma | 11 |
| Melanoma | 9 |
| Ovarian Neoplasms | 9 |
| Lung Neoplasms | 8 |
| Lymphoma | 8 |
| Testicular Neoplasms | 8 |
| Urinary Bladder Neoplasms | 8 |
Trials
Showing 1 to 25 of 140. Each trial links to its page on Pharma Observatory.
40 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.